3rd Quarter - Termination

TARPLIN, DOWNS & YOUNG, LLC for HANSA BIOPHARMA

Firm
Client
Income
$60,000
Expenses
—
Terminated
Aug 31, 2026

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Kidney issues, access to innovation, rare disease issues, organ rejection

LobbyistCovered position, as disclosed
PARICK BRAERTON CARROLL Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte.
CHARLOTTE SPEARS IVANCIC Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner
JEFF RECZEK New Dir. CDC Washington, Professional Staff Sen. Appropriations Cmte, Program Examiner OMB, Program Analyst Dept. of Transportation
PAMELA SMITH Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun
JENNIFER B YOUNG Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Budget/Appropriations BUD

Federal budget issues

LobbyistCovered position, as disclosed
PARICK BRAERTON CARROLL —
CHARLOTTE SPEARS IVANCIC —
JEFF RECZEK New —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.